ARCOMA.STARCOMA.STSTO
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -28.30% | -24.94% | -24.67% | -6.27% | -5.82% |
| Gross Profit Growth | +288.61% | -14.43% | +266.13% | -85.65% | -87.89% |
| EBITDA Growth | -8.15% | -32.40% | -66.67% | -8.80% | -28.07% |
| Operating Income Growth | -33.06% | -41.84% | -99.44% | -7.71% | -32.76% |
| Net Income Growth | -71.49% | -54.60% | -99.89% | -31.13% | +94.57% |
| EPS Growth | -71.32% | -52.94% | -99.89% | -35.29% | +79.08% |
| EPS Diluted Growth | -71.32% | -55.88% | -99.89% | -35.29% | +79.08% |
| Weighted Average Shares Growth | +0.00% | +0.00% | +0.00% | +8.52% | +8.52% |
| Weighted Average Shares Diluted Growth | -1.01% | +0.00% | -1.01% | +8.52% | +8.52% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -66.59% | -152.95% | +155.25% | -105.09% | +188.13% |
| Free Cash Flow Growth | -82.30% | -249.34% | +319.73% | -109.12% | +446.80% |
| Receivables Growth | -10.53% | -8.60% | -23.58% | +12.66% | +0.84% |
| Inventory Growth | -14.59% | +8.45% | +2.11% | -0.66% | -1.29% |
| Asset Growth | -1.83% | -3.42% | -3.31% | +12.23% | +20.12% |
| Book Value per Share Growth | +21.94% | +16.21% | +8.66% | +14.61% | +16.06% |
| Debt Growth | -100.00% | -100.00% | -100.00% | +0.00% | +0.00% |
| R&D Expense Growth | +8.00% | +0.00% | +0.00% | +0.00% | -100.00% |
| SG&A Expenses Growth | -10.07% | -100.00% | -100.00% | -100.00% | -100.00% |